GlassScriptPhysician profile
Donna M Greenfield
NPI 1710061155
$717.32
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $717.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $212.94 | 2021 | |
| Lilly USA, LLC | $89.00 | 2021 | |
| Novo Nordisk INC | $64.85 | 2021 | |
| Amgen INC. | $58.67 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $45.67 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.69 | 2021 | |
| Glaxosmithkline, LLC. | $33.22 | 2021 | |
| Sanofi-Aventis U.S. LLC | $33.01 | 2021 | |
| Collegium Pharmaceutical, INC. | $23.27 | 2021 | |
| Heron Therapeutics, INC. | $22.14 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.96 | 2021 | |
| Eisai INC. | $17.64 | 2021 | |
| Bausch Health US, LLC | $16.95 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.40 | 2021 | |
| Amarin Pharma, INC. | $12.37 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $11.54 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Greenfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.